Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Fidelma Russo, Executive Vice President and Chief Technology Officer at Hewlett Packard Enterprise Co (NYSE: HPE), sold 17,001 shares of company stock on April 21, 2026, in a transaction worth $475,517 under a trading plan adopted December 23, 2025. After the sale, Russo holds no direct common shares. The move coincides with a 92% year-over-year ri…
Neil B. MacDonald, Executive Vice President and General Manager of Server at Hewlett Packard Enterprise Co (NYSE: HPE), sold 24,251 shares on April 20, 2026, for about $654,975 under a trading plan adopted in September 2025. The sale occurred while HPE shares trade close to a 52-week high following a 92% return over the past year. The company recen…
Susan M Byrne, Director Emerita of Westwood Holdings Group Inc. (NASDAQ: WHG), disposed of 1,732 shares of common stock across three transactions between April 17 and April 21, 2026, for aggregate proceeds of $28,369. The trades were executed under a Rule 10b5-1 trading plan adopted April 1, 2026. After the sales Byrne retains 295,012 shares. The t…
Heritage Insurance Holdings CEO Ernie J. Garateix sold 8,334 shares worth $229,652 on April 20, 2026 under an existing Rule 10b5-1 plan. The transactions, executed at prices between $27.5245 and $28.4032 per share, come as the stock trades at $26.90 and follows quarterly results that beat expectations, driven by better underwriting and lower catast…
Najuma Atkinson, a director on Marqeta's board, sold 9,259 shares of Class A Common Stock on April 20, 2026, for a total of $41,121. The sales came days after a restricted stock unit vesting on April 17 that delivered 30,863 shares. Post-transaction, Atkinson directly holds 153,009.218 Class A shares. The stock trades near $4.42 and has risen rough…
Remitly Global, Inc. Chief Business Officer Pankaj Sharma exercised 10,000 options and sold the same number of common shares on April 17, 2026. The sale, executed under an existing Rule 10b5-1 trading plan, generated $200,000 at $20.00 per share after Sharma acquired the shares through option exercise at $1.70 per share. The company reported profit…
Michael Espensen, a director at Dolphin Entertainment, acquired 6,623 restricted stock units on March 30, 2026, according to an SEC filing. The awards were granted at no cost and will vest in four equal installments between May 15, 2026 and March 31, 2027. Dolphin reported a 10% year-over-year revenue increase to $56.7 million for the fourth quarte…
Bryan Lewis, CEO and President of Intellicheck, sold 10,000 shares of company common stock on April 20, 2026, for $85,145 under a Rule 10b5-1 plan established by The Lewis Family Revocable Living Trust. The sale occurred as Intellicheck shares traded near $8.68 after a 272% year-over-year price gain and followed quarterly results that topped analys…
Aparna Bawa, Chief Operating Officer of Zoom Communications, sold 12,886 shares of Class A common stock on April 17, 2026, in transactions totaling $1,129,109. The trades were carried out under a Rule 10b5-1 plan established June 4, 2025. The stock is trading at $90.95, roughly 10% higher over the past week, with a P/E of 14.86. Zoom recently repor…
Yeleswaram Krishnaswamy, Chief Development Officer of Rapport Therapeutics, sold 20,225 shares on April 17, 2026, for $808,844 under a pre-existing Rule 10b5-1 plan. The stock traded between $39.90 and $40.38 on the day of the sale and is currently at $36.95. Separately, the company reported strong Phase 2a results for RAP-219 and announced plans t…
Anang K. Majmudar, Senior Vice-President of General American Investors Co Inc (NYSE:GAM), purchased 500 shares of the firm’s 5.95% Preferred Stock on April 20, 2026 for $24.66 per share, a $12,330 transaction. The purchase raises his direct preferred-stock holding to 12,000 shares. The Form 4 reporting the trade was filed with the Securities and Ex…
Amazon Chief Executive Andrew R. Jassy sold 31,000 shares of Amazon common stock on April 17, 2026, in a transaction totaling $7,905,000 at $255.00 per share. The sale, completed under a Rule 10b5-1 trading plan adopted November 14, 2025, occurred while the stock traded close to a 52-week high and in the context of several company initiatives and a…
Kevin J. Khanna, an executive vice president at Fifth Third Bancorp, sold 6,000 shares of the bank's common stock on April 20, 2026, generating $304,630 at prices between $50.77 and $50.775 per share. After the transaction he holds 76,299 shares. The stock trades at $51.08, up 58% over the past year. Separately, Fifth Third reported Q1 2026 results…
Kurtis Joseph Binder, chief financial officer of Arlo Technologies, sold 25,000 shares of the company’s common stock on April 17, 2026, generating proceeds of $379,857. The transaction was carried out under a Rule 10b5-1 plan adopted in November 2025. Following the sale, Binder directly holds 564,885 shares. The sale comes against a backdrop of str…
Alejandro Perez, Senior Executive Vice President at Bank of New York Mellon Corp (BK), sold 12,504 shares on April 17, 2026, for about $1,713,155 and gifted 1,000 shares to a charitable donor-advised fund. After the transactions, Perez holds 62,612.7610 shares directly and 1,806.0786 shares indirectly in a 401(k). Analysts have raised price targets…
Phreesia Inc.'s general counsel, Allison C. Hoffman, disposed of 6,176 shares of the company's common stock on April 20, 2026, under a Rule 10b5-1 trading plan adopted in December 2025. The sale totaled $55,954. The filing arrives as Phreesia reported slightly better-than-expected fourth-quarter fiscal 2026 revenue and adjusted EBITDA, but the comp…
Kerry Wentworth, Nuvation Bio's Chief Regulatory Officer, sold 36,750 shares of Class A common stock on April 17, 2026 under a 10b5-1 trading plan. The transactions followed an option exercise and leave her holding 53,000 direct shares and 215,250 options. The disclosures arrive alongside corporate developments including an amended license agreemen…
Kurtis R. Kurimsky, corporate controller at Bank of New York Mellon Corp, sold 5,290 shares on April 17, 2026, for $719,523. The disposal occurred at a weighted average price of $136.0157 per share and left Kurimsky with 17,259 shares held directly. The transaction comes as BK shares trade close to a 52-week high and follows a quarter that prompted…
J. Kevin McCarthy, Senior Executive Vice President and General Counsel at Bank of New York Mellon Corp, sold 30,000 shares on April 17, 2026, totaling $4,094,919. The transaction took place while the stock traded close to its 52-week high and follows several analyst price-target increases after a strong first-quarter showing.
Adam Eltoukhy, Samsara Inc.'s Executive Vice President, Chief Legal Officer and Secretary, sold 5,473 shares of Class A common stock on April 20, 2026, for a total of $167,906 under a Rule 10b5-1 trading plan adopted March 28, 2025. The transactions consisted of multiple lots, including 5,373 shares at a weighted-average price of $30.6696 and 100 s…
W. Nicholas Howley, a TransDigm Group director, sold 10,132 shares through his family trust on April 20, 2026, generating roughly $12.8 million after exercising options for the same number of shares. The transactions leave the trust holding 21,547.513 shares. The company has reported preliminary quarterly results, completed multiple acquisitions, a…
Yvonne Hui, Principal Accounting Officer at Phreesia, Inc. (NASDAQ: PHR), sold 1,327 shares of company common stock on April 17, 2026, for $9.28 per share, generating $12,314 in proceeds. The filing shows Hui now directly holds 24,664 shares. The transaction was executed under a Rule 10b5-1 trading plan adopted January 15, 2026. The insider move co…
Equitable Holdings CEO Mark Pearson sold 39,700 shares under a pre-established Rule 10b5-1 plan on April 20, 2026, for about $1.65 million and exercised options to acquire 27,200 shares at $23.18 each. The transactions leave Pearson with 789,183.2978 shares. The stock trades at $41 with an $11.5 billion market cap amid mixed financial signals inclu…
Malik Fady Ibraham, executive vice president for research and development at Cytokinetics Inc. (NASDAQ: CYTK), sold 3,500 shares of company stock on April 21, 2026 for $65.69 per share, netting $229,915. The sale came after Dr. Malik exercised an equal number of non-qualified stock options at $7.80 per share. Following these moves, he holds 153,902…
Hallie E. Kuhn, Executive Vice President of Capital Markets and Co-Lead of Life Science at Alexandria Real Estate Equities, Inc. (NASDAQ: ARE), sold 536 shares of the company on April 17, 2026, realizing $25,835. The stock has recovered 7.9% over the past week after a six-month decline of 34% and currently trades near $47.81. Alexandria declared a …
